Rashid A, Sengar D P, Harris J E
Clin Exp Immunol. 1979 Jun;36(3):521-7.
The response of twelve cadaveric renal allograft recipients was serially studied in one-way MLC using the specific donor spleen lymphocytes as stimulating cells. The stimulation index (SI) progressively decreased between the second and the eighteenth post-transplantation week in the presence of normal plasma. The appearance of MLC non-reactivity (SI of less than 2.3) correlated well with the achievement of excellent graft function. In nine recipients allograft rejections have not occurred once the non-reactive state in cultures with normal plasma was established. In two of the recipients reactivity reappeared after an interval of non-reactive phase. In both instances rejection followed such reactivity and non-reactivity followed successful management of rejection. In one patient severe irreversible allograft rejection occurred in spite of the appearance of an early MLC non-reactive phase. This patient developed donor-specific lymphocytotoxic antibodies and his rejection was perhaps of antibody mediated type. Donor-specific MLC reactivity may represent cellular immune response of host to an allograft and predict cellular allograft rejection.
使用特定供体的脾淋巴细胞作为刺激细胞,通过单向混合淋巴细胞培养(MLC)对12例尸体肾移植受者的反应进行了系列研究。在正常血浆存在的情况下,刺激指数(SI)在移植后第二周和第十八周之间逐渐下降。MLC无反应性(SI小于2.3)的出现与优异的移植肾功能的实现密切相关。在9例受者中,一旦在含有正常血浆的培养物中建立了无反应状态,同种异体移植排斥反应就未发生。在2例受者中,在无反应期间隔后反应性重新出现。在这两种情况下,排斥反应都跟随这种反应性出现,而无反应性则跟随排斥反应的成功处理出现。在1例患者中,尽管出现了早期MLC无反应期,但仍发生了严重的不可逆同种异体移植排斥反应。该患者产生了供体特异性淋巴细胞毒性抗体,其排斥反应可能是抗体介导型的。供体特异性MLC反应性可能代表宿主对同种异体移植的细胞免疫反应,并预测细胞性同种异体移植排斥反应。